Litcius/Paper detail

A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers

Keith R. Edwards, Aneesh Kamath, Judy Button, Vineetha Kamath, Jason P. Mendoza, Bing Zhu, Tatiana Plavina, Caroline Woodward, Natalia A. Penner

2021Multiple Sclerosis and Related Disorders19 citationsDOI

Topics & Concepts

Dimethyl fumarateCerebrospinal fluidMultiple sclerosisMedicineBiomarkerGlial fibrillary acidic proteinNeuroprotectionPharmacokineticsPharmacologyInternal medicinePathologyGastroenterologyImmunologyChemistryBiochemistryImmunohistochemistryMultiple Sclerosis Research StudiesAmyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration Mechanisms
A pharmacokinetic and biomarker study of delayed-release dimethyl fumarate in subjects with secondary progressive multiple sclerosis: evaluation of cerebrospinal fluid penetration and the effects on exploratory biomarkers | Litcius